Boston Scientific recently shared new clinical data sets on the use of its Eluvia drug-eluting stent for treating peripheral ...

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES . Ghent, Belgium, 14 May 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequan ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

The VanEck Biotech ETF offers lower risk with established companies, but 23% of AUM in speculative stocks poses a risk. Check ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

A Davie mom fighting a rare and rapidly spreading cancer is enrolled in a pioneering clinical trial at Memorial Cancer ...

Americans are notoriously unhappy with healthcare. As of last December, Americans’ perception of the quality of US healthcare ...

Some new glow in the dark technology called Cytalux is helping remove cancer cells. Cytalux is the first and only ...

U.S. health officials are announcing an effort to phase out ingestible fluoride supplements used to strengthen children’s ...